| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |